Given the fact that the epidemiology and clinical behaviors of lung cancer is different between East Asians and Caucasians [20], we examined the BRAF V600E mutation and HER2 exon 20 insertions in Chinese lung ADC patients in order to determine the frequency of these two mutations and identify their clinicopathological characteristics. This evidence concerns the gene ERBB2 and lung cancer.